VYNDAMAX

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 7cadd8a7d426a02b
Drug Approval Canada Name: VYNDAMAX
Product Name: VYNDAMAX
Status: Marketed
Status Date: 2021-09-15
Original Market Date: 2021-09-15
Din: 02517841
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Atc Original: N07XX08 TAFAMIDIS
Atc Name: n 07 xx 08
Aig Number: 0163049001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

TAFAMIDIS

61 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7cadd8a7d426a02b

Type

Standard